Target intelligence / Profile preview

Essential cysteine-containing protein

Molecular classification
Enzyme, Protein
01

Overview

Essential cysteine-containing proteins in Dirofilaria immitis are a group of vital enzymes and structural proteins characterized by the presence of reactive thiol (sulfhydryl) groups (BenchChem, 2025). These proteins are primarily involved in the parasite's energy metabolism, specifically the glycolytic pathway, and its antioxidant defense systems, including enzymes like glutathione reductase and thioredoxin reductase (BenchChem, 2025; USP, 2008). Because adult heartworms reside in a low-oxygen environment and rely heavily on anaerobic glycolysis, these proteins are indispensable for their survival. Trivalent arsenical drugs, such as melarsomine dihydrochloride, target these proteins by forming stable covalent bonds with the cysteine residues, effectively inactivating the enzymes (Wikipedia, 2025; NCATS, 2016). This disruption of metabolic and redox homeostasis leads to the death of the adult worms. However, the use of drugs targeting these proteins requires careful clinical management due to the risk of host arsenic toxicity and the potential for pulmonary thromboembolism as the dead worms are cleared from the host's vasculature (USP, 2008; NIH, 1994). These proteins represent the primary target for adulticidal therapy in canine heartworm disease, and the specificity of arsenical drugs for the parasite's proteins over the host's is a key factor in their therapeutic index.

Other names
Essential thiol-containing proteinSulfhydryl-containing enzymeArsenical-binding proteinThiol-containing protein
02

Mechanism of action

Covalent binding of trivalent arsenic to sulfhydryl (thiol) groups of cysteine residues, leading to the inhibition of essential metabolic and antioxidant enzymes.

03

Biological functions

Energy metabolismAntioxidant defenseRedox homeostasisGlycolysis
04

Disease associations

InfectionDirofilariasis
05

Safety considerations

Arsenic toxicityPulmonary thromboembolismInjection site reactionsHepatotoxicityNephrotoxicity
06

Interacting drugs

Melarsomine dihydrochloride

1 more in the full profile.

07

Biomarkers

Heartworm antigenMicrofilariae count

Beyond the preview

Go deeper on Essential cysteine-containing protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Essential cysteine-containing protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call